News
Entertainment
Science & Technology
Life
Culture & Art
Hobbies
News
Entertainment
Science & Technology
Culture & Art
Hobbies
The firm, backed by Peter Thiel's Valar Ventures, has over $10bn of assets, is growing fast in Australia, Hong Kong and Singapore. Syfe's CEO told FA that management is open to exploring opportunities in Japan and South Korea in the "longer term".
Speaking to FinanceAsia, UBS’s Aaron Oh, Head of Equity Capital Markets (ECM) in Asia Pacific (Apac), and Ivy Hu, Head of ECM for China, reveal their optimism for a growing deal pipeline in the region – across types of equity transactions, sectors, and both public and private markets.
Amid volatility, dollar weakness, and high government debt, the global fixed income market is poised for a bumpy reset with more instruments in Asia to benefit, according to Andrew Jackson, head of investments and head of fixed income boutique, at Vontobel.
Three judges at the US Court of International Trade have argued the Trump administration has exceeded its authority over tariffs; the judgment, which came after 12 states filed a lawsuit, has been appealed and the decision temporarily paused by another court.
Shilpa Gulrajani, DBS' head of sustainable finance, institutional banking, offered her thoughts on how capital markets are aligning with the region’s transition needs, including green loans and blended finance, on the sidelines of Ecosperity Week.
Minority owner Partners Group said the IPO proceeds will be used to further grow the Hangzhou-headquartered restaurant's 493 outlets and establish a centralised food processing facility; Clifford Chance, Citi and CMB International Capital were involved in the deal.
Clean energy investments are ramping up in Apac, but a $800bn annual shortfall risks slowing momentum. At Temasek’s Ecosperity Week, IFC's Riccardo Puliti and BlackRock's Susan Chan called for bolder partnerships, clearer policies, and better capital mobilisation.
Markets have rallied after a weekend agreement to reduce tariffs to 10% in China and 30% in the US is good news for companies, markets, and the US dollar; however, pharmaceutical stocks are in focus as US president Donald Trump tries to reduce drug prices.